Log in or Sign up for Free to view tailored content for your specialty!
Lymphoma News
Patient-reported outcomes linked to nonfatal self-injury after cancer diagnosis
Self-reported signs of distress and an increasing total Edmonton Symptom Assessment System score within 180 days of cancer diagnosis appeared associated with higher odds of nonfatal, self-inflicted injury, study results showed.
MD Anderson launches James P. Allison immunotherapy institute to ‘enable cures’ for cancer
The University of Texas MD Anderson Cancer announced Thursday the launch of the James P. Allison Institute, a research and innovation hub that integrates immunobiology across disciplines to accelerate discoveries toward cancer cures.
Log in or Sign up for Free to view tailored content for your specialty!
Investigational therapy for B-cell malignancies offers three targets in one CAR T cell
B-cell activating factor is a ligand protein, which makes it uniquely suited as a therapeutic option for the newly emerging class of multitargeted chimeric antigen receptor T-cell therapies.
Early intrathecal therapy shows promise for managing neurotoxicity related to CAR-T
Early intrathecal therapy effectively resolved symptoms related to high-grade neurotoxicity among patients who received chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma, according to a research letter in JAMA Oncology.
ASCO members urged to help support cancer care in Ukraine, host countries
As important as the care of Ukrainian citizens with cancer is to clinicians in that country, this priority has been overshadowed by more immediate concerns.
Age at diagnosis and cancer subtype may affect risk for CV death among cancer survivors
Among survivors of nine common cancers, risk for CV death overtook cancer mortality for most cancer subtypes among patients aged at least 80 years, researchers reported.
‘Like’ it or not: The dos and don’ts of social media for oncologists
Just as physicians became accustomed to wearing pagers 40 years ago or being tied to smartphones 2 decades ago, many have become active on social media as it entered their practices.
In age of misinformation, cancer care community seeks new ways to improve communication
An important component of cancer care is communication with patients and caregivers about their disease.
New cancer diagnosis associated with risk for fatal, nonfatal cardiovascular events
New cancer diagnosis appeared associated with increased risk for cardiovascular death, as well as incident heart failure, stroke or pulmonary embolism, according to a retrospective cohort study published in JACC: CardioOncology.
Only 14% of new cancer drug approvals displace existing standards of care
Most cancer drug approvals between 2016 and 2021 applied to second-, third- or later-line treatment settings and did not displace current standard-of-care therapies, according to a study published in JAMA Network Open.